Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Peeps moving money into GDR
The board should be prosecuted. FCA should get involved
Code 1 printed for the believers. Tr1 coming up on seller. Good riddance
When shares go up without reason a speeding ticket is released. We need rns next week from the board to let us know why this is going down or should not be going down. We will have to wait and see. Gla who are still in this.
Looks like seller still around. The earliest they sell up the better.
Very well said windows. I agree to all you have written. I should not bought this share.
Buys coming in but no movement on the share price.
Canegrass Lithium Exploration Results
18 March 2024
Corcel plc, (London AIM: CRCL), the Angolan focused exploration and production company with battery metal interests, announces the results of its initial exploration activities at the Company's 100%-owned Canegrass lithium project, in Western Australia ("WA").
Corcel Executive Chairman, Antoine Karam, commented: "Intriguing initial results from the Company's recent work at its 100%-owned Canegrass lithium project in Western Australia indicate broader potential for the project than originally anticipated, reflecting historic interest in the area for both nickel and vanadium."
Lithium Exploration Results:
The Company commissioned APEX Geoscience ("APEX") to conduct a rock chip sampling and reconnaissance program at the Company's Canegrass Lithium project in Western Australia. The project consists of three active tenements, E 59/2119, E 59/2697 and E 59/2698, with the Company having lithium rights over all three tenements.
Mathew lodge selling out. Good riddance. This was held back due to him selling out.
Why are Mms printing buy as Unknown? They did the same thing yesterday. Is this to hold the price down?
Alderley Park, UK, 14 March 2024 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, targeted therapeutics for the treatment of fibrotic disease and cancer today announces that its Annual General Meeting was held at 11am on 14 March 2024, with all resolutions passed by substantial majorities.